Advertisement

Ad promo image large
  • Published Date

    August 14, 2019
    This ad was originally published on this date and may contain an offer that is no longer valid. To learn more about this business and its most recent offers, click here.

Ad Text

STEM CELL RECRUITMENT FOR KNEE PAIN, ARTHRITIS & JOINT PAIN COVERED BY MEDICARE & INSURANCE Indications for Cellular Regenerative Medicine Knee, Hip&Shoulder Arthritis August Only - No Charge Consultation "Bone-on-bone" Menicus Tears Avoid surgery& joint replacement Plantar fascitis Joint pain & inflammation Dr. David Rosania, MD CHICAGO Top Physician 2018 MAGAZNE 847-243-6991 4.85 OUT OF 5 STAR REVIEWS Leading Providers of Conservative Care 97% Patient Satisfaction 100% would recommend PRI Results based on 150 patients surveyed 30-90 days post stem celrecruitment overage varies by plan&carie Medicare coverage for qualified paternts Stem Cel Recruitment (SCR) is a trademark of Russel Health, Inc. The treatments descrbed onthis marketing are not considered to be standardof care for any condition or disease SCRatempts to ule minimaly manpulated amniotic fuid intended for homologous use to supplement issue These statements have not been evaluated by the FDA Results may vary See complete discoser at paintreepairelet.com STEM CELL RECRUITMENT FOR KNEE PAIN, ARTHRITIS & JOINT PAIN COVERED BY MEDICARE & INSURANCE Indications for Cellular Regenerative Medicine Knee, Hip&Shoulder Arthritis August Only - No Charge Consultation "Bone-on-bone" Menicus Tears Avoid surgery& joint replacement Plantar fascitis Joint pain & inflammation Dr. David Rosania, MD CHICAGO Top Physician 2018 MAGAZNE 847-243-6991 4.85 OUT OF 5 STAR REVIEWS Leading Providers of Conservative Care 97% Patient Satisfaction 100% would recommend PRI Results based on 150 patients surveyed 30-90 days post stem celrecruitment overage varies by plan&carie Medicare coverage for qualified paternts Stem Cel Recruitment (SCR) is a trademark of Russel Health, Inc. The treatments descrbed onthis marketing are not considered to be standardof care for any condition or disease SCRatempts to ule minimaly manpulated amniotic fuid intended for homologous use to supplement issue These statements have not been evaluated by the FDA Results may vary See complete discoser at paintreepairelet.com